GABARAPL1 antibody (N-Term)
Quick Overview for GABARAPL1 antibody (N-Term) (ABIN7468359)
Target
See all GABARAPL1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Cross-Reactivity
- Human, Mouse, Rat
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Carrier-protein conjugated synthetic peptide encompassing a sequence within the N-terminus region of human GABARAPL1. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Comment
-
Positive Control: U87MG , SKNSH , mouse brain , rat brain Validation: Comparison, Orthogonal
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.3 mg/mL
-
Buffer
- 1XPBS ( pH 7), 1 % BSA, 20 % Glycerol, 0.025 % ProClin 300
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- GABARAPL1 (GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1))
-
Alternative Name
- GABA type A receptor associated protein like 1
-
Background
-
Synonyms: GABA type A receptor associated protein like 1 , APG8-LIKE , APG8L , ATG8 , ATG8B , ATG8L , GEC1
Background: Increases cell-surface expression of kappa-type opioid receptor through facilitating anterograde intracellular trafficking of the receptor.
-
Molecular Weight
- 14 kDa
-
Gene ID
- 23710
-
UniProt
- Q9H0R8
-
Pathways
- Autophagy
Target
-